Burning Rock Biotech Ltd.-ADRBNR
13F holders, Q2 2026 (June 30)At the end of Q2 2026, 17 institutions reported holding Burning Rock Biotech Ltd.-ADR (BNR) in their 13F filings, up 1 from Q1 2026. 3 opened new positions and 1 sold out. The largest holders were Kynam Capital Management, LP ($10.5M), CRCM LP ($1.8M) and Renaissance Technologies ($442K). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Burning Rock Biotech Ltd.-ADR
- CUSIP
- 12233L206
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $255K |
| Exits | 1 | $16 |
All 13F filers, Q1 2026 → Q2 2026: 114,994 shares bought and 70,948 shares sold, net +44,046 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 17 holders
| Kynam Capital Management, LP | 0.58% | Add +0.9% | 1,238,563 | $10.5M |
| CRCM LP | 1.17% | Reduce -24.9% | 211,997 | $1.8M |
| Renaissance Technologies | 0.00% | Add +49.2% | 52,838 | $442K |
| Morgan Stanley | 0.00% | Add +185.4% | 43,594 | $365K |
| Amova Asset Management Americas, Inc. | 0.00% | Reduce -1.4% | 29,724 | $258K |
| Sumitomo Mitsui Trust Group, Inc. | 0.00% | Reduce -1.4% | 29,724 | $249K |
| Bank of America Corp. | 0.00% | No change | 29,164 | $244K |
| Citadel Advisors | 0.00% | Add +54.4% | 27,288 | $237K |
| HSG Holding Ltd | 0.01% | No change | 21,212 | $178K |
| UBS Group AG | 0.00% | Add +4291.2% | 17,916 | $150K |
| Almanack Investment Partners, LLC. | 0.02% | New | 16,198 | $136K |
| XTX Topco Ltd | 0.00% | New | 13,621 | $118K |
| BNP Paribas Financial Markets | 0.00% | No change | 2,800 | $23K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +4335.7% | 1,242 | $10K |
| JPMorgan Chase & Co. | 0.00% | Reduce -11.2% | 166 | $1K |
| Royal Bank of Canada | 0.00% | New | 73 | $1K |
| BlackRock, Inc. | 0.00% | No change | 4 | $33 |
"% of holder's portfolio" is BNR's weight in each manager's 13F, not the share of Burning Rock Biotech Ltd.-ADR the manager owns.